ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL1991A |
|
252003-71-7 |
CP-547632 hydrochloride 98+% |
C20H24BrF2N5O3S·HCl | |
CL2953A |
|
1702864-11-6 |
FF-10101 succinate 98+% |
C33H44N8O6 | |
CL2954 |
|
1370256-78-2 |
SKLB4771 | FLT3-IN-1 98+% |
C25H27N7O3S2 | |
CL2953 |
|
1472797-69-5 |
FF-10101 98+% |
C29H38N8O2 | |
CL2895 |
|
937263-43-9 |
Tucatinib | Irbinitinib | ARRY-380 | ONT-380 99+% |
C26H24N8O2 | |
CL2888 |
|
905854-02-6 |
Tivantinib | ARQ-197 98+% |
C23H19N3O2 | |
CL2879 |
|
252916-29-3 |
Orantinib | SU 6668 | TSU-68 98+% |
C18H18N2O3 | |
CL2840 |
|
1353552-97-2 |
Poseltinib | HM71224 | LY3337641 98+% |
C26H26N6O3 | |
CLA1680 |
|
2648260-93-7 |
Becotatug (JMT-101) 98+% |
— | |
CL2721 |
|
1538604-68-0 |
BLU9931 98+% |
C26H22Cl2N4O3 | |
CL2671 |
|
1108743-60-7 |
Entrectinib 98+% |
C31H34F2N6O2 | |
CL2550 |
|
953769-46-5 |
Sotuletinib (BLZ945) 98+% |
C20H22N4O3S | |
CL2536 |
|
1020172-07-9 |
Rebastinib (DCC-2036) 98+% |
C30H28FN7O3 | |
CL2519 |
|
950769-58-1 |
Quizartinib (AC220) 98+% |
C29H32N6O4S | |
CL2508 |
|
1360460-82-7 |
Anlotinib Dihydrochloride (AL3818 Dihydrochloride); Anlotinib 2HCl 98+% |
C23H24Cl2FN3O3 | |
CL2492A |
|
1421783-64-3 |
Olverembatinib dimesylate (GZD824 dimesylate; HQP1351 dimesylate) 98+% |
C31H35F3N6O7S2 | |
CL2492 |
|
1257628-77-5 |
Olverembatinib (GZD824; HQP1351) 98+% |
C29H27F3N6O | |
HL1454 |
|
442-51-3 |
Harmine(Banisterine);7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole; 7-Methoxy-1-methyl-9H-beta-carboline;7-methoxy-1-methyl-9H-pyrido[3,4-b]indole 98+% |
C13H12N2O | |
CL2480 |
|
796967-16-3 |
Linifanib(ABT-869; AL-39324; RG3635) 99+% |
C21H18FN5O | |
CL2468 |
|
867160-71-2 |
Linsitinib (OSI-906) 98+% |
C26H23N5O | |